LIGAND PHARMACEUTICALS INC — Director's Dealing 2015

Dec 10, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LIGAND PHARMACEUTICALS INC (LGND)
CIK: 0000886163
Period of Report: 2015-12-07

Reporting Person: Davis Todd C (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-12-07	Common Stock	G	50.0	—	Disposed	55399	Direct

Footnotes

F1: Charitable gift to a third party.